• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    1/31/24 1:18:09 PM ET
    $AHT
    $AMD
    $AMSC
    $ASH
    Real Estate Investment Trusts
    Real Estate
    Semiconductors
    Technology
    Get the next $AHT alert in real time by email

    Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) shares declined 3.8% to $165.49 following fourth-quarter results.

    AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion.

    AMD shares dipped 3.8% to $165.49 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) shares jumped 204% to $0.6049. Connexa said it has regained compliance with Nasdaq minimum shareholder equity rule.
    • Minim, Inc. (NASDAQ:MINM) shares climbed 76.4% to $4.48. David E. Lazar disclosed a 51% active stake in Minim Inc.
    • Powell Industries, Inc. (NASDAQ:POWL) shares gained 49% to $121.89 after the company reported better-than-expected first-quarter financial results and raised its quarterly dividend.
    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) climbed 46.5% to $0.1180 after falling around 7% on Tuesday.
    • Ashford Hospitality Trust, Inc. (NYSE:AHT) jumped 32% to $1.77.
    • 2seventy bio, Inc. (NASDAQ:TSVT) rose 31.6% to $5.28. 2seventy Bio said it will focus exclusively on commercialization and development of Abecma and sell its R&D pipeline to Regeneron. Leerink Partners analyst Daina Graybosch upgraded 2seventy bio from Market Perform to Outperform and raised the price target from $5 to $18.
    • Trinity Biotech plc (NASDAQ:TRIB) gained 29.5% to $0.5638. Trinity Biotech announced acquisition of the CGM assets of Waveform Technologies, Inc.
    • Kuke Music Holding Limited (NYSE:KUKE) rose 23.7% to $1.25.
    • Vaxart, Inc. (NASDAQ:VXRT) jumped 20.9% to $1.1850. B. Riley Securities analyst Mayank Mamtani upgraded Vaxart from Neutral to Buy and announced a $2 price target.
    • Envirotech Vehicles, Inc. (NASDAQ:EVTV) gained 20.6% to $1.75.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) gained 19.6% to $1.7232. Ensysce Biosciences reported completion of a constructive end of Phase 2 meeting with the FDA regarding its lead 'next generation' analgesic, PF614.
    • Plug Power Inc. (NASDAQ:PLUG) climbed 17.8% to $4.3950 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4.5 to $9.
    • DocGo Inc. (NASDAQ:DCGO) gained 15.8% to $3.9497 after the company announced a share buyback program of up to $36 million.
    • Ashland Inc. (NYSE:ASH) jumped 14.5% to $92.50 after the company reported mixed first-quarter financial results and issued guidance.
    • Jin Medical International Ltd. (NASDAQ:ZJYL) rose 12.5% to $236.64.
    • LendingClub Corporation (NYSE:LC) gained 12.3% to $9.81 after the company reported better-than-expected quarterly financial results.
    • Nomura Holdings, Inc. (NYSE:NMR) rose 12.2% to $5.84 following third-quarter results.
    • Paramount Global (NASDAQ:PARA) gained 10.4% to $15.10. Byron Allen offered $14.3 billion to buy all of the outstanding shares of Paramount Global, Bloomberg reported.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) gained 10.3% to $8.77 after dipping around 39% on Tuesday.
    • Nyxoah S.A. (NASDAQ:NYXH) shares rose 9.1% to $8.88 after dipping 34% on Tuesday.
    • Stryker Corporation (NYSE:SYK) gained 5.8% to $335.28 after the company reported better-than-expected fourth-quarter financial results.

    Losers

    • Nuvve Holding Corp. (NASDAQ:NVVE) shares dipped 65.8% to $1.1401. Nuvve announced pricing of $9.6 million underwritten public offering of 4.8 million shares of common stock at $2.00 per share.
    • Remark Holdings, Inc. (NASDAQ:MARK) shares fell 36% to $0.80. Remark Holdings shares jumped 264% on Tuesday following a Tweet from the company's X account suggesting an unconfirmed deal with Microsoft..
    • New York Community Bancorp, Inc. (NYSE:NYCB) fell 34.5% to $6.80 after the company reported worse-than-expected fourth-quarter financial results and reduced its quarterly dividend.
    • GRI Bio, Inc. (NASDAQ:GRI) fell 28.6% to $2.05.
    • Genprex, Inc. (NASDAQ:GNPX) declined 28% to $0.1931. Genprex announced a 1-for-40 reverse stock split effective Feb. 2, 2024.
    • Evaxion Biotech A/S (NASDAQ:EVAX) fell 24% to $4.3999.
    • TuSimple Holdings Inc. (NASDAQ:TSP) declined 23.4% to $0.2220.
    • Rail Vision Ltd. (NASDAQ:RVSN) fell 21.9% to $11.70.
    • American Superconductor Corporation (NASDAQ:AMSC) shares declined 18.2% to $0.20 after the company announced a proposed public offering of common stock.
    • Extreme Networks, Inc. (NASDAQ:EXTR) fell 15.8% to $14.02 after the company reported mixed second-quarter financial results and issued guidance.
    • Rockwell Automation, Inc. (NYSE:ROK) declined 15.3% to $260.07 following weak earnings.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares fell 14.2% to $0.4067 after jumping 47% on Tuesday.
    • Synaptogenix, Inc. (NASDAQ:SNPX) fell 13% to $0.1864 after gaining 12% on Tuesday.
    • LSB Industries, Inc. (NYSE:LXU) fell 9.5% to $7.51. UBS analyst Joshua Spector downgraded LSB Industries from Buy to Neutral and lowered the price target from $11 to $9.
    • MarketAxess Holdings Inc. (NASDAQ:MKTX) fell 8.8% to $250.01 following weak sales.
    • Teradyne, Inc. (NASDAQ:TER) shares declined 8.2% to $95.99 after the company posted downbeat fourth-quarter sales and issued weak forecast for the first quarter.
    • Oblong, Inc. (NASDAQ:OBLG) declined 8.1% to $0.20 trading after gaining around 24% on Tuesday.
    • Solid Biosciences Inc. (NASDAQ:SLDB) fell 7.5% to $7.47.
    • Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) shares fell 6.2% to $143.60. Alphabet posted better-than-expected earnings results for its fourth quarter on Tuesday. However, Google’s advertising sales came in short of market estimates.
    • Heartland Financial USA, Inc. (NASDAQ:HTLF) fell 5.5% to $36.54.
    • Group 1 Automotive, Inc. (NYSE:GPI) fell 5.5% to $266.64 after the company reported mixed fourth-quarter financial results.
    • Novartis AG (NYSE:NVS) fell around 3% to $104.69 following weak quarterly results.

     

    Now Read This: Bitcoin Falls Below $43,000 Following ADP Report; Blur, Manta Network Among Top Losers

    Get the next $AHT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHT
    $AMD
    $AMSC
    $ASH

    CompanyDatePrice TargetRatingAnalyst
    LSB Industries Inc.
    $LXU
    4/7/2026$14.00Outperform → Sector Perform
    RBC Capital Mkts
    Advanced Micro Devices Inc.
    $AMD
    4/3/2026Hold → Buy
    Erste Group
    Advanced Micro Devices Inc.
    $AMD
    4/2/2026Hold → Buy
    Erste Group
    Rockwell Automation Inc.
    $ROK
    3/31/2026$380.00Buy → Hold
    Jefferies
    Group 1 Automotive Inc.
    $GPI
    3/30/2026$425.00Hold → Buy
    The Benchmark Company
    Alphabet Inc.
    $GOOGL
    3/27/2026$387.00 → $397.00Overweight
    Wells Fargo
    Solid Biosciences Inc.
    $SLDB
    3/20/2026$26.00Buy
    Guggenheim
    MarketAxess Holdings Inc.
    $MKTX
    3/17/2026Buy → Hold
    Argus
    More analyst ratings

    $AHT
    $AMD
    $AMSC
    $ASH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 1, 2024 - FDA Roundup: November 1, 2024

    For Immediate Release: November 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub,” by Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER) and Peter Marks, M.D., Ph.D., director

    11/1/24 3:18:19 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Crespo Jose Luis bought $87,282 worth of shares (37,300 units at $2.34), increasing direct ownership by 14% to 307,332 units (SEC Form 4)

    4 - PLUG POWER INC (0001093691) (Issuer)

    12/17/25 9:06:21 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Director Watson W. Mark bought $8,185 worth of shares (20,000 units at $0.41), increasing direct ownership by 19% to 124,125 units (SEC Form 4)

    4 - Vaxart, Inc. (0000072444) (Issuer)

    12/5/25 5:46:47 PM ET
    $VXRT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Heron Elaine J bought $15,921 worth of shares (40,000 units at $0.40), increasing direct ownership by 71% to 96,566 units (SEC Form 4)

    4 - Vaxart, Inc. (0000072444) (Issuer)

    11/21/25 1:21:51 PM ET
    $VXRT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    LSB Industries downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded LSB Industries from Outperform to Sector Perform and set a new price target of $14.00

    4/7/26 8:40:27 AM ET
    $LXU
    Major Chemicals
    Basic Materials

    Advanced Micro Devices upgraded by Erste Group

    Erste Group upgraded Advanced Micro Devices from Hold to Buy

    4/3/26 10:44:58 AM ET
    $AMD
    Semiconductors
    Technology

    Advanced Micro Devices upgraded by Erste Group

    Erste Group upgraded Advanced Micro Devices from Hold to Buy

    4/2/26 9:28:21 AM ET
    $AMD
    Semiconductors
    Technology

    $AHT
    $AMD
    $AMSC
    $ASH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Concannon Christopher R

    4 - MARKETAXESS HOLDINGS INC (0001278021) (Issuer)

    4/6/26 4:15:07 PM ET
    $MKTX
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by O'Toole Amie Thuener

    4 - Alphabet Inc. (0001652044) (Issuer)

    4/3/26 5:31:35 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    SEC Form 4 filed by Bulho Matheus De A G Viera

    4 - ROCKWELL AUTOMATION, INC (0001024478) (Issuer)

    4/3/26 5:17:00 PM ET
    $ROK
    Industrial Machinery/Components
    Industrials

    $AHT
    $AMD
    $AMSC
    $ASH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Solid Biosciences to Participate at Upcoming Investor Conferences

    CHARLESTOWN, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 25th Annual Needham Virtual Healthcare ConferenceBo Cumbo, President and CEO, will participate in a virtual fireside chat on Tuesday, April 14, 2026, at 2:15 pm ET.A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. The webcast replay will be archived for 90 days on the Events page. Piper Sandler Spring Biopharma

    4/7/26 8:00:00 AM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01

    Trial extension completed as planned with three-year clinical efficacy data expected to be presented in the second half of 2026The trial has already yielded encouraging one- and two-year data including a 75% Objective Response Rate COPENHAGEN, Denmark, April 7, 2026 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has successfully completed the one-year extension of its phase 2 trial with personalized cancer vaccine EVX-01 with the last patient having now had last physician visit. Patients in the trial will continue to be monitored and data prepared for expected presentation in the second half of

    4/7/26 8:00:00 AM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement

    CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has received written notification from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement. The Company regained compliance after its Class A ordinary shares maintained a closing bid price of at least $1.00 per share for more than ten (10) consecutive business days.T

    4/7/26 7:00:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    SEC Filings

    View All

    SEC Form 6-K filed by Evaxion A/S

    6-K - Evaxion A/S (0001828253) (Filer)

    4/7/26 8:05:06 AM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Nuvve Holding Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Financial Statements and Exhibits

    8-K - Nuvve Holding Corp. (0001836875) (Filer)

    4/6/26 4:31:24 PM ET
    $NVVE
    Electrical Products
    Industrials

    SEC Form 144 filed by Advanced Micro Devices Inc.

    144 - ADVANCED MICRO DEVICES INC (0000002488) (Subject)

    4/6/26 4:14:57 PM ET
    $AMD
    Semiconductors
    Technology

    $AHT
    $AMD
    $AMSC
    $ASH
    Leadership Updates

    Live Leadership Updates

    View All

    LSB Industries, Inc. Appoints Jonathan Ackerman as an Independent Member of the Board of Directors; Announces Retirement of Steve Packebush

    LSB Industries, Inc. ("LSB" or "the Company"), (NYSE:LXU) today announced that it has appointed Jonathan Z. Ackerman as an independent member of the Board of Directors (the "Board") effective April 2, 2026. Mr. Ackerman will stand for direct election by shareholders for the first time at the annual meeting of stockholders on May 21, 2026 (the "2026 Annual Meeting"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402484774/en/Jonathan Ackerman Mr. Ackerman has a lengthy track record as a successful leader in infrastructure development and finance. He has successfully delivered approximately $10 billion of value for investors b

    4/2/26 5:38:00 PM ET
    $LXU
    Major Chemicals
    Basic Materials

    GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

    GE HealthCare (NASDAQ:GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE:SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities. "Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and s

    3/17/26 9:00:00 AM ET
    $GEHC
    $SYK
    Medical Electronics
    Health Care
    Medical/Dental Instruments

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    Financials

    Live finance-specific insights

    View All

    Rail Vision Announces Second Half and Full Year 2025 Financial Results

    Company presents strong balance sheet with year-end cash of approximately $20 million and zero debt Revenue up 14.4% year-over-year Ra'anana, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN, FSE: C80)) ("Rail Vision" or the "Company"), an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing systems, today announced its financial results for the second half and full year ended December 31, 2025. The Company reported revenue growth and operational progress, strengthening its global market presence. "2025 was a transformative year for Rail Vision," said David BenDavid, Chief Executive Officer. "We advan

    3/31/26 4:02:00 PM ET
    $RVSN
    Railroads
    Industrials

    Nuvve to Provide Fourth Quarter Ended December 31, 2025, Financial Update

    Investor Conference Call to be Held Tuesday, March 31, 2026, at 5:00 PM Eastern Time (2:00 PM PT) Nuvve Holding Corp. ("Nuvve") (NASDAQ:NVVE), a global leader in grid modernization and vehicle-to-grid (V2G) technology, will provide Fourth quarter ended December 31, 2025, update on Tuesday, March 31, 2026. Conference Call Details Nuvve will hold a conference call to review its financial results for the fourth quarter ended December 31, 2025, along with other company developments at 5:00 PM Eastern Time (2:00 PM PT), Tuesday, March 31, 2026. To participate in the call, please dial (888) 349-0097 or (412) 902-4245; Passcode: 7091129, or register for and listen via a live webcast, which

    3/26/26 8:00:00 AM ET
    $NVVE
    Electrical Products
    Industrials

    Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

    Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech's New York Reference Laboratory DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a global diagnostics company, today announced successful results from a clinical study of a new, enhanced version of its EpiCapture™ prostate cancer test, engineered to deliver higher precision risk prediction of aggressive prostate cancer. This next-generation version of EpiCapture™ utilizes machine learning tools that integrate additional patient features, including patient ethnicity in conjunction with the DNA biomarkers

    3/23/26 9:23:07 AM ET
    $TRIB
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by DocGo Inc.

    SC 13D/A - DocGo Inc. (0001822359) (Subject)

    11/29/24 4:14:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Minim Inc.

    SC 13D/A - MINIM, INC. (0001467761) (Subject)

    11/15/24 5:00:07 PM ET
    $MINM
    Telecommunications Equipment
    Utilities

    Amendment: SEC Form SC 13D/A filed by Solid Biosciences Inc.

    SC 13D/A - Solid Biosciences Inc. (0001707502) (Subject)

    11/14/24 7:59:25 PM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care